| Deborah C Eisenberg, MD | |
|
24 Miles Center Way, Damariscotta, ME 04543-4047 | |
| (207) 563-4700 | |
| (207) 563-4019 |
| Full Name | Deborah C Eisenberg |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 36 Years |
| Location | 24 Miles Center Way, Damariscotta, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275679938 | NPI | - | NPPES |
| 079031 | Other | ME | ANTHEM BCBS |
| 416930099 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 016620 (Maine) | Secondary |
| 207V00000X | Obstetrics & Gynecology | MD16620 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lincolnhealth | Damariscotta, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainehealth | 7517860588 | 2067 |
News Archive
Merck and Cardiome Pharma Corp. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing approval for BRINAVESS® (vernakalant), an investigational intravenous (IV) formulation for the conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults.
A 10% tax on sugar-sweetened drinks in Mexico has been associated with a 12% cut in sales just one year after its implementation, according to a study published in The BMJ. The sugar tax was also associated with a 4% increase in the purchase of untaxed beverages.
MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received a Small Business Innovation Research Grant (SBIR) from the National Cancer Institute (NCI) under the agency's Streamlined Non-competing Award Procedures (SNAP).
A surge in insured patients using health services has increased hospital revenues, even as Medicare stiffens penalties for facilities with high readmission rates or patients who contract infections and injuries while admitted for other reasons.
ThermoGenesis Corp., a leading supplier of innovative products for processing and storing adult stem cells, said today its Res-Q(TM) 60 BMC ("Res-Q") System has demonstrated positive outcomes in its initial applications, according to its orthopedic distribution partner Celling Technologies, a subsidiary of SpineSmith, LLC.
› Verified 1 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Merck and Cardiome Pharma Corp. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing approval for BRINAVESS® (vernakalant), an investigational intravenous (IV) formulation for the conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults.
A 10% tax on sugar-sweetened drinks in Mexico has been associated with a 12% cut in sales just one year after its implementation, according to a study published in The BMJ. The sugar tax was also associated with a 4% increase in the purchase of untaxed beverages.
MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received a Small Business Innovation Research Grant (SBIR) from the National Cancer Institute (NCI) under the agency's Streamlined Non-competing Award Procedures (SNAP).
A surge in insured patients using health services has increased hospital revenues, even as Medicare stiffens penalties for facilities with high readmission rates or patients who contract infections and injuries while admitted for other reasons.
ThermoGenesis Corp., a leading supplier of innovative products for processing and storing adult stem cells, said today its Res-Q(TM) 60 BMC ("Res-Q") System has demonstrated positive outcomes in its initial applications, according to its orthopedic distribution partner Celling Technologies, a subsidiary of SpineSmith, LLC.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deborah C Eisenberg, MD 24 Miles Center Way, Damariscotta, ME 04543-4047 Ph: (207) 563-4700 | Deborah C Eisenberg, MD 24 Miles Center Way, Damariscotta, ME 04543-4047 Ph: (207) 563-4700 |
News Archive
Merck and Cardiome Pharma Corp. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing approval for BRINAVESS® (vernakalant), an investigational intravenous (IV) formulation for the conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults.
A 10% tax on sugar-sweetened drinks in Mexico has been associated with a 12% cut in sales just one year after its implementation, according to a study published in The BMJ. The sugar tax was also associated with a 4% increase in the purchase of untaxed beverages.
MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received a Small Business Innovation Research Grant (SBIR) from the National Cancer Institute (NCI) under the agency's Streamlined Non-competing Award Procedures (SNAP).
A surge in insured patients using health services has increased hospital revenues, even as Medicare stiffens penalties for facilities with high readmission rates or patients who contract infections and injuries while admitted for other reasons.
ThermoGenesis Corp., a leading supplier of innovative products for processing and storing adult stem cells, said today its Res-Q(TM) 60 BMC ("Res-Q") System has demonstrated positive outcomes in its initial applications, according to its orthopedic distribution partner Celling Technologies, a subsidiary of SpineSmith, LLC.
› Verified 1 days ago
Patrick M. O'brien, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 24 Miles Center Way, Damariscotta, ME 04543 Phone: 207-563-1234 | |
William D Riley, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 35 Miles St, Miles Medical Group Billing, Damariscotta, ME 04543 Phone: 207-563-4511 Fax: 207-563-4103 | |
Robert T. Howard Iii, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 24 Miles Center Way, Damariscotta, ME 04543 Phone: 207-563-4700 Fax: 207-563-4019 |